Directed expression of an oncogene to sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences

Jacques J. Peschon, Richard R. Behringer, Richard L. Cate, Kimberly A. Harwood, Rejean L. Idzerda, Ralph L. Brinster, Richard D. Palmiter

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Abstract

Mullerian inhibiting substance (MIS) is a glycoprotein hormone expressed by Sertoli cells that induces the regression of Mullerian ducts during development of the male reproductive tract. Transgenic mice carrying a fusion gene composed of human MIS transcriptional regulatory sequences linked to the SV40 T-antigen gene specifically develop testicular tumors composed of a cell type histologically resembling the Sertoli cell. The lack of pathology at other sites suggests tissue-restricted expression of the transgene. A cell line derived from one of the testicular tumors has been established that continues to express markers associated with Sertoli cells, such as transferrin, sulfated glycoprotein-2, and inhibin-βB. The cell line does not express detectable levels of inhibin-α, MIS, or FSH receptor. However, the cells have retained forskolin responsiveness. As adult Sertoli cells cannot be propagated in vitro, the availability of an immortal cell line displaying features characteristic of normal Sertoli cells should aid in subsequent analyses of the biology of this cell type.

Original languageEnglish (US)
Pages (from-to)1403-1411
Number of pages9
JournalMolecular Endocrinology
Volume6
Issue number9
StatePublished - 1992

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Fingerprint

Dive into the research topics of 'Directed expression of an oncogene to sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences'. Together they form a unique fingerprint.

Cite this